Griseofulvin 125 mg / 5mL Suspension 120 mL
Reference details for licensed healthcare facility review and verification.
| NDC 11 | 00472-0013-04 |
|---|---|
| Product NDC | 00472-0013 |
| Generic Drug Name | Griseofulvin |
| Brand Name | Griseofulvin |
| Manufacturer | Actavis Pharma, Inc. |
| Strength | 125 mg / 5mL |
| Dosage Form | Suspension |
| Drug Type | Oral |
| Package Quantity | 120 mL |
| Package Description | 120 mL in 1 BOTTLE (0472-0013-04) |
| Active Ingredients | Griseofulvin |
| Marketing Category | ANDA |
Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.
NDC snapshot
Griseofulvin 125 mg / 5mL Suspension is tracked under NDC 00472-0013-04 and rolls up into product family 00472-0013. Use this page to review package-level identifiers before comparing related family pages or starting a quote review.
- Package configuration: 120 mL.
- Manufacturer: Actavis Pharma, Inc..
- Dosage form: Suspension.
- Family size: 1 indexed presentation.
Click a tag to refine the catalog view around this product reference.
Official references
Use official labeling and directory references to confirm presentation details while your team reviews the PRN catalog entry and related sourcing paths.
Drug Shortage Information
Public sources include an exact DailyMed label for the NDC and an FDA shortage portal page that can support shortage-history research.
This section is intended to help healthcare teams review public shortage history and related availability references for this product. Supply conditions can change quickly across manufacturers, distributors, and care settings, and these references may not reflect the latest market status. Premium Rx National does not guarantee completeness or suitability for clinical, operational, or purchasing decisions. Please confirm current availability with FDA, manufacturers, and other authoritative sources before relying on this information.
Griseofulvin 125 mg / 5mL Suspension 120 mL, NDC 00472-0013-04, is a Actavis Pharma, Inc. 125 mg / 5mL suspension presentation packaged as 120 mL. Historical public shortage information is available for this product reference.
NDC search formats
- Canonical NDC 11: 00472-0013-04
- Digits-only NDC 11: 00472001304
- Possible 10-digit display formats: 0472-0013-04 (0472001304), 00472-013-04 (0047201304), 00472-0013-4 (0047200134)
Multiple 10-digit display-format aliases can map to the same stored 11-digit billing NDC, so these are shown as search aliases rather than a single asserted package format.
Helpful product links
- Search by brand name: Griseofulvin
- NDC 11: 00472-0013-04
- Product family NDC: 00472-0013
- VA classification code: AM700
- VA classification code description: ANTIFUNGALS
- CMOP ID: G0074
- VUID: 4004157